Selexipag Patent Expiration
Selexipag is Used for treating pulmonary arterial hypertension. It was first introduced by Actelion Pharmaceuticals Us Inc
Selexipag Patents
Given below is the list of patents protecting Selexipag, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Uptravi | US10821108 | Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide | Dec 01, 2036 | Actelion |
| Uptravi | US10828298 | Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsulfonyl)acetamide | Dec 01, 2036 | Actelion |
| Uptravi | US8791122 | Form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and method for producing the same | Aug 01, 2030 | Actelion |
| Uptravi | US9284280 | Use of form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide | Jun 25, 2030 | Actelion |
| Uptravi | US9173881 | Therapeutic compositions containing macitentan | Aug 12, 2029 | Actelion |
| Uptravi | US7205302 | Heterocyclic compound derivatives and medicines | Oct 31, 2026 | Actelion |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Selexipag's patents.
Latest Legal Activities on Selexipag's Patents
Given below is the list recent legal activities going on the following patents of Selexipag.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 Apr, 2024 | US10828298 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Apr, 2024 | US10821108 |
| Court Processing Terminated | 02 Apr, 2024 | US7205302 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Aug, 2023 | US9284280 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 Apr, 2023 | US9173881 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 12 Jan, 2022 | US8791122 |
| Patent Term Extension Certificate Critical
| 12 Nov, 2021 | US7205302 |
| Notice of Final Determination -Eligible | 09 Mar, 2021 | US7205302 |
| Case Docketed to Examiner in GAU Critical
| 06 Jan, 2021 | US7205302 |
| Patent Issue Date Used in PTA Calculation Critical
| 10 Nov, 2020 | US10828298 |
Selexipag's Family Patents
